Your browser doesn't support javascript.
loading
Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea.
Lee, Hankil; Cho, Hyeonseok; Han, Jung Woo; Kim, Ah-Young; Park, Seonyoung; Lee, Minjun; Cho, Sunghwa; Baik, Deborah; Kang, Hye-Young.
  • Lee H; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, South Korea.
  • Cho H; CONNECT-AI Research Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Han JW; Institute of Health Services Research, Yonsei University College of Medicine, Seoul, South Korea.
  • Kim AY; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, South Korea.
  • Park S; Department of Pediatrics, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.
  • Lee M; Department of Pediatric Hemato-oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea.
  • Cho S; Department of Pharmaceutical Medicine and Regulatory Sciences, Colleges of Medicine and Pharmacy, Yonsei University, Incheon, South Korea.
  • Baik D; Department of Pharmaceutical Medicine and Regulatory Sciences, Colleges of Medicine and Pharmacy, Yonsei University, Incheon, South Korea.
  • Kang HY; Department of Pharmaceutical Medicine and Regulatory Sciences, Colleges of Medicine and Pharmacy, Yonsei University, Incheon, South Korea.
Haemophilia ; 27(1): e12-e21, 2021 Jan.
Article en En | MEDLINE | ID: mdl-32894895

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Hemofilia A Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Hemofilia A Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article